368 related articles for article (PubMed ID: 29304208)
1. What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.
Bassetti M; Righi E; Montravers P; Cornely OA
J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i14-i25. PubMed ID: 29304208
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Candidemia and invasive candidiasis in adults: A narrative review.
Antinori S; Milazzo L; Sollima S; Galli M; Corbellino M
Eur J Intern Med; 2016 Oct; 34():21-28. PubMed ID: 27394927
[TBL] [Abstract][Full Text] [Related]
4. Épico Project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3):135-49. PubMed ID: 23727234
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species.
Ou HT; Lee TY; Chen YC; Charbonneau C
BMC Infect Dis; 2017 Jul; 17(1):481. PubMed ID: 28693479
[TBL] [Abstract][Full Text] [Related]
6. Treatment of invasive candidiasis: between guidelines and daily clinical practice.
Tagliaferri E; Menichetti F
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):685-9. PubMed ID: 25818660
[TBL] [Abstract][Full Text] [Related]
7. Changes in the epidemiological landscape of invasive candidiasis.
Lamoth F; Lockhart SR; Berkow EL; Calandra T
J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i4-i13. PubMed ID: 29304207
[TBL] [Abstract][Full Text] [Related]
8. Invasive candidiasis.
Pappas PG; Lionakis MS; Arendrup MC; Ostrosky-Zeichner L; Kullberg BJ
Nat Rev Dis Primers; 2018 May; 4():18026. PubMed ID: 29749387
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated candidiasis and the emerging concern of Candida auris infections.
Tsai CS; Lee SS; Chen WC; Tseng CH; Lee NY; Chen PL; Li MC; Syue LS; Lo CL; Ko WC; Hung YP
J Microbiol Immunol Infect; 2023 Aug; 56(4):672-679. PubMed ID: 36543722
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.
Pfaller MA; Andes DR; Diekema DJ; Horn DL; Reboli AC; Rotstein C; Franks B; Azie NE
PLoS One; 2014; 9(7):e101510. PubMed ID: 24991967
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
Wang H; Xu YC; Hsueh PR
Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
Lepak AJ; Zhao M; Berkow EL; Lockhart SR; Andes DR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584152
[No Abstract] [Full Text] [Related]
13. The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris.
Quindós G; Marcos-Arias C; San-Millán R; Mateo E; Eraso E
Int Microbiol; 2018 Sep; 21(3):107-119. PubMed ID: 30810955
[TBL] [Abstract][Full Text] [Related]
14. [Épico project: Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Grupo Proyecto Épico].
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3 Suppl 1):135-49. PubMed ID: 23764554
[TBL] [Abstract][Full Text] [Related]
15. Echinocandin Susceptibility Profile of Fluconazole Resistant Candida Species Isolated from Blood Stream Infections.
Deorukhkar SC; Saini S
Infect Disord Drug Targets; 2016; 16(1):63-8. PubMed ID: 26648186
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi V; Schizodimos T; Kotoulas SC
Infection; 2021 Dec; 49(6):1107-1131. PubMed ID: 34132989
[TBL] [Abstract][Full Text] [Related]
17. Invasive Candidiasis.
Gonzalez-Lara MF; Ostrosky-Zeichner L
Semin Respir Crit Care Med; 2020 Feb; 41(1):3-12. PubMed ID: 32000280
[TBL] [Abstract][Full Text] [Related]
18. Antifungals in the ICU.
Playford EG; Eggimann P; Calandra T
Curr Opin Infect Dis; 2008 Dec; 21(6):610-9. PubMed ID: 18978529
[TBL] [Abstract][Full Text] [Related]
19. Candida glabrata--unique features and challenges in the clinical management of invasive infections.
Glöckner A; Cornely OA
Mycoses; 2015 Aug; 58(8):445-50. PubMed ID: 26207423
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy.
Lichtenstern C; Nguyen TH; Schemmer P; Hoppe-Tichy T; Weigand MA
Mycoses; 2008; 51 Suppl 1():35-46. PubMed ID: 18471160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
